Application and Impact of Antiviral Therapy for Patients with HBV-Related Hepatocellular Carcinoma Receiving Sorafenib and Lenvatinib Treatment

Overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) has improved in the era of multi-line sequential therapy. The application of antiviral therapy and its impact on survival for patients with HBV-related HCC needs to be reassessed. The aim of this study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, I-Cheng, Lee, Pei-Chang, Chao, Yee, Chi, Chen-Ta, Wu, Chi-Jung, Hung, Yi-Ping, Su, Chien-Wei, Hou, Ming-Chih, Huang, Yi-Hsiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692815/
https://www.ncbi.nlm.nih.gov/pubmed/36366452
http://dx.doi.org/10.3390/v14112355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692815/
https://www.ncbi.nlm.nih.gov/pubmed/36366452
http://dx.doi.org/10.3390/v14112355

Ejemplares similares